TY  - GEN
AU  - Colombat,P
AU  - Brousse,N
AU  - Salles,G
AU  - Morschhauser,F
AU  - Brice,P
AU  - Soubeyran,P
AU  - Delwail,V
AU  - Deconinck,E
AU  - Haioun,C
AU  - Foussard,C
AU  - Sebban,C
AU  - Tilly,H
AU  - Thieblemont,C
AU  - Bergougnoux,L
AU  - Lazreg,F
AU  - Solal-Celigny,P
TI  - Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
SN  - 1569-8041
PY  - 2012///1226
KW  - Adult
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunization, Passive
KW  - Induction Chemotherapy
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Rituximab
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mds177
ER  -